Anti-cancer Drug Targeting using Stimuli Sensitive Mesoporous Silica Nanoparticle in Colorectal Cancer
- Authors: Mainuddin 1, Kumar A.2, Sharma A.3, Sharma N.4
-
Affiliations:
- Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University
- Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology
- Department of Pharmaceutical Technology, Lloyd Institute of Management & Technology
- Department of Pharmaceutics, Amity Institute of Pharmacy,, Amity University
- Issue: Vol 30, No 39 (2024)
- Pages: 3071-3073
- Section: Immunology, Inflammation & Allergy
- URL: https://vestnikugrasu.org/1381-6128/article/view/645966
- DOI: https://doi.org/10.2174/0113816128321020240903100601
- ID: 645966
Cite item
Full Text
About the authors
Mainuddin
Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University
Email: info@benthamscience.net
Anoop Kumar
Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology
Email: info@benthamscience.net
Anjana Sharma
Department of Pharmaceutical Technology, Lloyd Institute of Management & Technology
Email: info@benthamscience.net
Nitin Sharma
Department of Pharmaceutics, Amity Institute of Pharmacy,, Amity University
Author for correspondence.
Email: info@benthamscience.net
References
- Rahmani F, Zandigohar M, Safavi P, et al. The interplay between noncoding RNAs and p21 signaling in gastrointestinal cancer: From tumorigenesis to metastasis. Curr Pharm Des 2023; 29(10): 766-76. doi: 10.2174/1381612829666230306123455 PMID: 36876835
- Sharma N, Kumari R, Karwasra R, Khanna K. Colon cancer and their targeting approaches through nanocarriers: A review. Asian Pac J Trop Biomed 2023; 13(3): 104-11. doi: 10.4103/2221-1691.372283
- Hofmann B. Ethical issues with colorectal cancer screening-a systematic review. J Eval Clin Pract 2017; 23(3): 631-41. doi: 10.1111/jep.12690 PMID: 28026076
- Marin JJ, Romero MR, Blazquez AG, Herraez E, Keck E, Briz O. Importance and limitations of chemotherapy among the available treatments for gastrointestinal tumours. Anticancer Agents Med Chem 2009; 9(2): 162-84. doi: 10.2174/187152009787313828
- Watermann A, Brieger J. Mesoporous silica nanoparticles as drug delivery vehicles in cancer. Nanomaterials (Basel) 2017; 7(7): 189. doi: 10.3390/nano7070189
- Meng J, Wang ZG, Zhao X, et al. Silica nanoparticle design for colorectal cancer treatment: Recent progress and clinical potential. World J Clin Oncol 2024; 15(6): 667-73. doi: 10.5306/wjco.v15.i6.667 PMID: 38946830
- Feng W, Zhou X, He C, et al. Polyelectrolyte multilayer functionalized mesoporous silica nanoparticles for pH-responsive drug delivery: Layer thickness-dependent release profiles and biocompatibility. J Mater Chem B Mater Biol Med 2013; 1(43): 5886-98. doi: 10.1039/c3tb21193b PMID: 32261055
- Baeza A, Colilla M, Vallet-Regí M. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery. Expert Opin Drug Deliv 2015; 12(2): 319-37. doi: 10.1517/17425247.2014.953051 PMID: 25421898
- Narayan R, Gadag S, Cheruku SP, et al. Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy. Carbohydr Polym 2021; 261: 117893. doi: 10.1016/j.carbpol.2021.117893 PMID: 33766378
- Thirupathi K, Santhamoorthy M, Radhakrishnan S, et al. Thermosensitive polymer-modified mesoporous silica for pH and temperature-responsive drug delivery. Pharmaceutics 2023; 15(3): 795. doi: 10.3390/pharmaceutics15030795
- Zou Z, He X, He D, et al. Programmed packaging of mesoporous silica nanocarriers for matrix metalloprotease 2-triggered tumor targeting and release. Biomaterials 2015; 58: 35-45. doi: 10.1016/j.biomaterials.2015.04.034 PMID: 25941780
- Yang X, Liu X, Liu Z, Pu F, Ren J, Qu X. Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles. Adv Mater 2012; 24(21): 2890-5. doi: 10.1002/adma.201104797
- Al-Mosawi AKM, Bahrami AR, Nekooei S, Saljooghi AS, Matin MM. Using magnetic mesoporous silica nanoparticles armed with EpCAM aptamer as an efficient platform for specific delivery of 5-fluorouracil to colorectal cancer cells. Front Bioeng Biotechnol 2023; 10: 1095837.
- Iranpour S, Bahrami AR, Nekooei S, Sh Saljooghi A, Matin MM. Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy. J Nanobiotechnol 2021; 19(1): 314. doi: 10.1186/s12951-021-01056-3 PMID: 34641857
- He X, Zhao Y, He D, Wang K, Xu F, Tang J. ATP-responsive controlled release system using aptamer-functionalized mesoporous silica nanoparticles. Langmuir 2012; 28(35): 12909-15. doi: 10.1021/la302767b PMID: 22889263
Supplementary files
